MENU
Showcases Stock ranks Forex

Zosano Pharma (ZSAN)
1.06  -0.02 (-1.85%) 01-25 16:00
Open: 1.08 Pre. Close: 1.08
High: 1.0887 Low: 1
Volume: 5,331,368 Market Cap: 108M
Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The company is headquartered in Fremont, California and currently employs 53 full-time employees. The firm is focused on providing systemic administration of therapeutics to patients using its Adhesive Dermally-Applied Microarray (ADAM) technology. ADAM is an intracutaneous delivery system designed to offer drug absorption into the bloodstream. ADAM consists of an array of drug-coated titanium microneedles mounted on an adhesive backing that is pressed on to the skin using a reusable handheld applicator. The Company’s Qtrypta (M207) is a formulation of zolmitriptan delivered utilizing its ADAM technology. Qtrypta (M207) is being investigated as a treatment to provide relief of migraine symptoms in the migraine cycle. The firm has developed its transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 1.092 - 1.097 1.097 - 1.102
Low: 0.988 - 0.994 0.994 - 0.998
Close: 1.052 - 1.061 1.061 - 1.068
Stock Technical Analysis
Overall:     
Target: Six months: 1.53
One year: 1.79
Support: Support1: 0.82
Support2: 0.52
Resistance: Resistance1: 1.31
Resistance2: 1.53
Pivot: 0.90
Moving Averages: MA(5): 1.05
MA(20): 0.82
MA(100): 0.83
MA(250): 0.87
MACD: MACD(12,26): 0.12
Signal(12,26,9): 0.09
%K %D: %K(14,3): 68.93
%D(3): 71.62
RSI: RSI(14): 69.15
52-Week: High: 1.96
Low: 0.328
Change(%): -18.5
Average Vol(K): 3-Month: 693758
10-Days: 1224203
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

ZSAN has closed below upper band by 21.2%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 22 Jan 2021
Zosano Pharma (NASDAQ:ZSAN) Lowered to Hold at Zacks Investment Research - MarketBeat

Fri, 22 Jan 2021
Zosano Pharma Corporation - Consensus Indicates Potential 61.9% Upside - DirectorsTalk Interviews

Thu, 21 Jan 2021
Should You Buy Zosano Pharma Corp (ZSAN) Stock Thursday? - InvestorsObserver

Thu, 21 Jan 2021
Zosano Pharma (ZSAN) Crosses $1 Mark on High Volume: A Bullish Sign? – Own Snap - Own Snap

Wed, 20 Jan 2021
Thinking about buying stock in Zosano Pharma, Senseonics, Tellurian, Cinedigm, or AMC Entertainment? - Benzinga

Tue, 12 Jan 2021
Zosano Pharma (ZSAN) in Focus: Stock Moves 6.3% Higher - Yahoo Finance

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 102.07
Shares Float (M) 101.94
% Held by Insiders 0.36
% Held by Institutions 15.59
Shares Short (K) 6850
Shares Short Prior Month (K) 7850
Stock Financials
EPS -0.727
Book Value (p.s.) 0.540
Profit Margin
Operating Margin
Return on Assets (ttm) -35.8
Return on Equity (ttm) -104.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.249
Sales Per Share
EBITDA (p.s.) -0.318
Qtrly Earnings Growth
Operating Cash Flow (M) -32.90
Levered Free Cash Flow (M) -27.88
Stock Valuation
PE Ratio -1.46
PEG Ratio
Price to Book value 1.96
Price to Sales
Price to Cash Flow -3.29
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator